Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP710598.RAKYhVpOgFuUEUPE32IsJ-BJtkt7WWB9dzlSlni1VYUXw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP710598.RAKYhVpOgFuUEUPE32IsJ-BJtkt7WWB9dzlSlni1VYUXw130_assertion type Assertion NP710598.RAKYhVpOgFuUEUPE32IsJ-BJtkt7WWB9dzlSlni1VYUXw130_head.
- NP710598.RAKYhVpOgFuUEUPE32IsJ-BJtkt7WWB9dzlSlni1VYUXw130_assertion description "[To determine if mutation of HGF/MET pathway genes is a mechanism for pathway dysregulation, we conducted a mutational analysis by exon resequencing of three key components of this pathway, including serine protease inhibitor Kunitz-type 1 (SPINT1), serine protease inhibitor Kunitz-type 2 (SPINT2), and MET, in 32 primary human medulloblastoma specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710598.RAKYhVpOgFuUEUPE32IsJ-BJtkt7WWB9dzlSlni1VYUXw130_provenance.
- NP710598.RAKYhVpOgFuUEUPE32IsJ-BJtkt7WWB9dzlSlni1VYUXw130_assertion evidence source_evidence_literature NP710598.RAKYhVpOgFuUEUPE32IsJ-BJtkt7WWB9dzlSlni1VYUXw130_provenance.
- NP710598.RAKYhVpOgFuUEUPE32IsJ-BJtkt7WWB9dzlSlni1VYUXw130_assertion SIO_000772 22447520 NP710598.RAKYhVpOgFuUEUPE32IsJ-BJtkt7WWB9dzlSlni1VYUXw130_provenance.
- NP710598.RAKYhVpOgFuUEUPE32IsJ-BJtkt7WWB9dzlSlni1VYUXw130_assertion wasDerivedFrom befree-20150227 NP710598.RAKYhVpOgFuUEUPE32IsJ-BJtkt7WWB9dzlSlni1VYUXw130_provenance.
- NP710598.RAKYhVpOgFuUEUPE32IsJ-BJtkt7WWB9dzlSlni1VYUXw130_assertion wasGeneratedBy ECO_0000203 NP710598.RAKYhVpOgFuUEUPE32IsJ-BJtkt7WWB9dzlSlni1VYUXw130_provenance.